We are live on ! Find out more
AKBA icon

Akebia Therapeutics

86 hedge funds and large institutions have $176M invested in Akebia Therapeutics in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 27

20% more capital invested

Capital invested by funds: $147M → $176M (+$29.2M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 9386 (-7)

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

49% less call options, than puts

Call options by funds: $1.47M | Put options by funds: $2.86M

Holders
86
Holders Change
-7
Holders Change %
-7.53%
% of All Funds
2.29%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
33
Reduced
27
Closed
15
Calls
$1.47M
Puts
$2.86M
Net Calls
-$1.4M
Net Calls Change
-$46K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
26
Segantii Capital Management
Hong Kong
$897K +$874K +102,810 New
Wells Fargo
27
Wells Fargo
California
$761K +$8.09K +952 +1%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$688K +$5.95K +700 +0.9%
BCM
29
Bridgeway Capital Management
Texas
$588K
TA
30
Teachers Advisors
New York
$555K
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$534K
SIM
32
Spark Investment Management
New York
$469K +$441K +51,900 New
AA
33
ALPS Advisors
Colorado
$439K -$41.6K -4,890 -9%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$421K +$6.04K +710 +2%
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$339K +$106K +12,527 +50%
Creative Planning
36
Creative Planning
Kansas
$338K
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$336K +$75.7K +8,900 +32%
Millennium Management
38
Millennium Management
New York
$299K -$180K -21,182 -39%
MLICM
39
Metropolitan Life Insurance Company (MetLife)
New York
$288K -$18.5K -2,182 -6%
Group One Trading
40
Group One Trading
Illinois
$271K +$45.8K +5,389 +22%
VEA
41
Virtus ETF Advisers
New York
$268K
RJA
42
Raymond James & Associates
Florida
$260K +$49.4K +5,809 +25%
ProShare Advisors
43
ProShare Advisors
Maryland
$249K -$43.7K -5,146 -16%
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$239K +$995 +117 +0.4%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$211K -$9.57K -1,126 -5%
Simplex Trading
46
Simplex Trading
Illinois
$204K +$47.3K +5,567 +33%
NFA
47
Nationwide Fund Advisors
Ohio
$199K +$9K +1,059 +5%
HCM
48
Highbridge Capital Management
New York
$195K +$183K +21,586 New
AIG
49
American International Group
New York
$187K +$264 +31 +0.1%
CS
50
Credit Suisse
Switzerland
$183K -$103K -12,139 -37%

AKBA Hedge Fund Activity: Q3 2016 in Review

86 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q3 2016, worth a combined $176M — up 20% from $147M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of AKBA and 8 opened new positions — a net loss of 7 holders — while 27 trimmed existing stakes and 33 added.

The largest buyer was Avoro Capital Advisors, adding an estimated $2.74M. The largest seller was Fidelity Investments, cutting an estimated $6.43M.

  • 86 institutional investors held Akebia Therapeutics (AKBA) as of Q3 2016, down from 93 in Q2 2016.
  • Funds reported $176M of Akebia Therapeutics stock for Q3 2016, up 20% quarter-over-quarter.
  • 8 funds opened new Akebia Therapeutics positions in Q3 2016 and 15 closed out, a net change of -7 holders.
  • The largest Akebia Therapeutics buyer in Q3 2016 was Avoro Capital Advisors, an estimated $2.74M added.
  • The largest Akebia Therapeutics seller in Q3 2016 was Fidelity Investments, an estimated $6.43M sold.

Based on aggregated 13F filings for Q3 2016.